What is the optimal management approach for a 75-year-old patient with stable angina (angina pectoris), hypertension, macular degeneration, mild cognitive impairment, and cervical osteoarthritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: March 23, 2025 • View editorial policy

From the Guidelines

The optimal management approach for a 75-year-old patient with stable angina, hypertension, macular degeneration, mild cognitive impairment, and cervical osteoarthritis involves a comprehensive care plan that addresses all conditions while minimizing polypharmacy. For stable angina, a regimen including low-dose aspirin (81mg daily), a moderate-intensity statin like atorvastatin 20mg daily, and as-needed nitroglycerin 0.4mg sublingual tablets for chest pain is appropriate, as recommended by 1. Hypertension management should target a blood pressure of <130/80 mm Hg, using medications that don't exacerbate cognitive impairment, such as an ACE inhibitor (lisinopril 5-10mg daily) or ARB, as suggested by 2. For macular degeneration, AREDS2 vitamin supplementation daily is recommended along with regular ophthalmology follow-ups. Mild cognitive impairment requires cognitive stimulation, regular exercise, and avoiding anticholinergic medications. Cervical osteoarthritis can be managed with physical therapy, acetaminophen (up to 3000mg daily in divided doses), and topical NSAIDs to avoid systemic side effects. Regular comprehensive geriatric assessments every 6 months are essential to monitor disease progression and medication effectiveness while maintaining quality of life and functional independence. Key considerations in managing this patient include:

  • Monitoring symptoms and adjusting antianginal therapy as needed, based on expert opinion from 3
  • Evaluating the patient's tolerance to therapy and modifying the treatment plan accordingly
  • Encouraging risk factor modification and patient education about ischemic heart disease
  • Assessing for new comorbid illnesses or worsening of existing conditions that may impact angina management. Overall, the goal is to provide comprehensive care that addresses all aspects of the patient's health while prioritizing their quality of life and functional independence, as emphasized by 4 and 5.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Management of Stable Angina and Hypertension

  • The optimal management approach for a 75-year-old patient with stable angina and hypertension may involve the use of beta-blockers, such as metoprolol, which has been shown to be effective in reducing the risk of mortality and morbidity in patients with hypertension and angina pectoris 6.
  • The use of aspirin, a statin, and blood pressure-lowering agents, such as those found in a polypill, may also be beneficial in reducing the risk of vascular morbidity and mortality in patients with coronary artery disease 7.
  • However, the use of aspirin for primary prevention of cardiovascular disease in adults 60 years or older has been found to have no net benefit, and its use should be individualized based on the patient's risk factors and bleeding risk 8.

Management of Macular Degeneration

  • For the patient's macular degeneration, the use of VEGF inhibitors, such as aflibercept, may be beneficial in preventing vision loss and improving visual acuity 9.
  • Aflibercept has been shown to be effective in reducing the risk of vision loss and improving visual acuity in patients with wet age-related macular degeneration.

Management of Mild Cognitive Impairment

  • For the patient's mild cognitive impairment, a multi-faceted knowledge translation approach, such as the cognitive orientation to daily occupational performance (CO-OP) approach, may be beneficial in improving functional outcomes and self-efficacy 10.
  • This approach involves a combination of education, training, and support for healthcare professionals, as well as patients and their families, to improve the management of cognitive impairment and promote functional recovery.

Management of Cervical Osteoarthritis

  • There is limited evidence available on the optimal management approach for cervical osteoarthritis in the context of the patient's other comorbidities.
  • However, a comprehensive management plan that takes into account the patient's overall health status, functional abilities, and quality of life is likely to be the most effective approach.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.